ANGLE plc (GB:AGL) has released an update.
ANGLE plc, a leading liquid biopsy company, will announce its interim results for the first half of 2024 on September 26, 2024, with an analyst meeting and live webcast scheduled at Berenberg’s London office. The webcast will be accessible through the company’s Investor Centre, with a recording available post-event. ANGLE specializes in circulating tumor cell solutions and offers diagnostic products and clinical services through its FDA cleared Parsortix system.
For further insights into GB:AGL stock, check out TipRanks’ Stock Analysis page.
